These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24713440)
1. Predictors of exacerbation frequency in chronic obstructive pulmonary disease. Yang H; Xiang P; Zhang E; Guo W; Shi Y; Zhang S; Tong Z Eur J Med Res; 2014 Apr; 19(1):18. PubMed ID: 24713440 [TBL] [Abstract][Full Text] [Related]
2. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ; Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356 [TBL] [Abstract][Full Text] [Related]
3. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related]
5. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study. Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794 [TBL] [Abstract][Full Text] [Related]
6. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers? Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820 [TBL] [Abstract][Full Text] [Related]
7. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study. Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628 [TBL] [Abstract][Full Text] [Related]
9. Correlation of frequency of exacerbations with the BODE index in COPD patients. Hodgev VA; Kostianev SS; Marinov BA Folia Med (Plovdiv); 2006; 48(2):18-22. PubMed ID: 17408072 [TBL] [Abstract][Full Text] [Related]
10. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease. Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777 [TBL] [Abstract][Full Text] [Related]
11. Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population. Dalal AA; Patel J; D'Souza A; Farrelly E; Nagar S; Shah M J Manag Care Spec Pharm; 2015 Jul; 21(7):575-83. PubMed ID: 26108382 [TBL] [Abstract][Full Text] [Related]
12. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Donaldson GC; Seemungal TA; Bhowmik A; Wedzicha JA Thorax; 2002 Oct; 57(10):847-52. PubMed ID: 12324669 [TBL] [Abstract][Full Text] [Related]
13. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease. Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174 [TBL] [Abstract][Full Text] [Related]
14. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715 [TBL] [Abstract][Full Text] [Related]
15. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785 [TBL] [Abstract][Full Text] [Related]
16. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation. Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405 [TBL] [Abstract][Full Text] [Related]
17. Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program. van Ranst D; Stoop WA; Meijer JW; Otten HJ; van de Port IG Int J Chron Obstruct Pulmon Dis; 2014; 9():1059-67. PubMed ID: 25336938 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 is a Strong Predictor of the Frequency of COPD Exacerbation Within 1 Year. Huang H; Huang X; Zeng K; Deng F; Lin C; Huang W Int J Chron Obstruct Pulmon Dis; 2021; 16():2945-2951. PubMed ID: 34737559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]